Health Canada requested on May 1st, 2008 (file number: 08-111801-312) that all manufacturers of licensed Class II, III and IV medical devices inform Health Canada by 1 June 2009 whether any of their devices which come into contact with the patient or patient fluids and are manufactured from raw materials containing or derived from BPA